Conference Details

2009 Best Practices in Primary Care
10/9/2009
Hilton St. Louis Frontenac
1335 S Lindbergh Blvd.
St. Louis , MO 63131
Phone: 314-993-1100

Who Should Attend

All primary care clinicians (physicians, physician assistants, and nurse practitioners) who are active in patient care.

Agenda

 
10/9/2009
6:30 am - 7:30 am Registration and Complimentary Continental Breakfast
7:30 am - 12:25 pm Morning Sessions
12:25 pm - 1:10 pm Complimentary Lunch
1:10 pm - 5:30 pm Afternoon Sessions

Venue Information

Meeting Room: Ambassadeur Ballroom

Complimentary Self Parking is offered.

Hotel Accommodations:
With so many things to do and see, you might consider bringing your family and turning this conference trip into a vacation at the Hilton St. Louis Frontenac. Please call 314-993-1100 and mention that you are with the Primary Care Education conference. Be sure to call no later than September 24, 2009, to guarantee your room rate of $109 for single/double occupancy per night. Rooms are limited!

Accreditation

ACCME
Primary Care Network, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Primary Care Network designates this educational activity for a maximum of 7.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AAFP
This activity has been reviewed and is acceptable for up to 7.75 Prescribed credits by the American Academy of Family Physicians.

AANP
This program has been approved for 7.75 contact hours of continuing education (which includes 3.25 hours of pharmacology) by the American Academy of Nurse Practitioners. Program ID 0909334. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.

AAPA
AAPA accepts certificates of participation for educational activities certified for Category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 7.75 hours of Category 1 credit for completing this program.

Topics

 
 Atherothrombosis
 Prevent The Event: Defining The Role of Oral Antiplatelet Therapy in Atherothrombosis

Overview
Atherothrombosis is the leading cause of death worldwide and the underlying process in the etiology of acute coronary syndrome (ACS), stroke and vascular death. Cardiovascular risk factors such as obesity, the metabolic syndrome, diabetes mellitus, hypertension, smoking and other "lifestyle" risks contribute to this pandemic of atherothrombotic disease. Patients with ACS, stroke/TIA and PAD (peripheral arterial disease), present major challenges to the primary care clinician in terms of managing CV risk factors and prevention of a second event. This lecture will overview current studies and treatment guidelines for PAD, ACS and Stroke and explore the role of primary care in long-term treatment of these patients.

Objectives
Describe 3 clinical conditions in which dual antiplatelet therapy is recommended

Name 5 treatment recommendations for reduction of global CV risk

Faculty
Jerome D. Cohen, MD, FACP, FACC, FAHA
Professor of Internal Medicine
Saint Louis University School of Medicine
St. Louis, MO

David S. Kountz, MD, FACP
Associate Professor of Medicine
Robert Wood Johnson
Medical School
New Brunswick, NJ


 Smoking Cessation
 Do Ask, Do Tell: Successful Smoking Interventions

Overview
Smoking is the single most important preventable cause of death in the United States. This session, "Do Ask, Do Tell: Successful Smoking Interventions", will address practical ways primary care clinicians can help their patients quit smoking.

Objectives
Screen all patients for smoking status and design individualized cessation interventions for patients who smoke

Commit to active follow-up with patients along the smoking cessation path

Faculty
Lesley A. Schroeder, MD
Associate Clinical Professor
Department of Psychiatry & Behavioral Sciences
University of CA-Davis
Sacramento, CA

 Sleep-Wake
 Do Patients with Sleep-Wake Disorders Keep YOU up at Night? Strategies for Identifying and Managing Patients with a "Sleep Debt"

Overview
The diagnosis, treatment, and on-going management of patients with sleep disorders, which affect 21% of the population, are most commonly the responsibility of the primary care clinician. Utilizing effective screening tools, distinguishing primary versus secondary sleep disorders, recognizing comorbid conditions, and developing a treatment strategy based on individual patient factors can all present as challenges. This activity will provide the information and case-based scenarios to maximize outcomes for patients with sleep disorders.

Objectives
Integrate the use of screening tools to differentiate primary versus secondary sleep disorders

Identify the treatment strategies based on individual patient factors and characteristics

Faculty
Joseph A. Lieberman III, MD, MPH
Professor of Family Medicine
Jefferson Medical College
Thomas Jefferson University
Associate Editor, Delaware Medical Journal
Philadelphia, PA

Michael J. Thorpy, MD
Professor of Neurology
Albert Einstein College of Medicine
Bronx, NY


 Migraine
 Diagnosis and Effective Treatment of Migraine to Limit Allodynia and Progression to Chronic Headache

Overview
This educational activity will describe and reinforce tools that enable clinicians to efficiently recognize and diagnose migraine that may have been previously undiagnosed and untreated, or who may have lapsed from treatment, and to communicate realistic treatment goals to reach the goal of improved patient outcomes.

Objectives
Identify the symptoms and patterns of headache for accurate assessment of migraine, including associated risks for progression to chronic migraine, and utilize simple screening tools to overcome diagnostic challenges

Create a migraine management strategy tailored to individual patient needs that incorporates a stratified approach to pharmacological and nonpharmacological therapies and communication of realistic treatment goals to help improve patient outcomes

Faculty
Frederick R. Taylor, MD, FAHS
Adjunct Professor of Neurology
University of Minnesota School of Medicine
Director, Park Nicollet Headache Clinic and Research Center
Minneapolis, MN

Susan Hutchinson, MD
Associate Clinical Professor
Department of Family Medicine
University of CA, Irvine Medical Center
Irvine, CA

 Adult Vaccines
 Adult Immunizations: Overcoming Obstacles in Primary Care

Overview
Despite the great advances in medical care represented by adult immunization, the challenges continue to be numerous and varied. This activity will explore the barriers, clarify the "myths," and provide the most updated information on adult vaccines to increase immunization rates.

Objectives
Identify the Advisory Committee on Immunization Practices (ACIP) recommended adult vaccines and the recommended immunization schedules for each ACIP recommended adult vaccine

Increase knowledge and confidence regarding safety, risks, benefits, and side effects of adult immunizations and create a strategy to increase patient immunization rates, including the use of a health maintenance form or other tool for immunization review

Faculty
Iyabode F. Akinsanya-Beysolow, MD, MPH
Medical Officer
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Atlanta, GA

 Gout
 Front-line Management of Gout: A Step-by-Step Guide to Best Practice

Overview
This program will address the key "must-know" points in gout management. The provision of case-based presentations will provide primary care clinicians with a clear step-by-step comprehension of how to manage gout and establish effective, supportive patient interaction to optimize life-long adherence to life-style and therapeutic regimens. There will be opportunities to interact with the faculty and obtain their expert opinions on clinical issues faced in managing patients with gout.

Objectives
Identify that the long-term goal of gout treatment is to reduce serum urate to <6.0 mg/dL and to define the key steps in selecting and individualizing urate lowering therapy according to the disease stage; together with recognizing the importance of monitoring serum urate levels

Educate patients that an important factor in successful management includes their long-term commitment to adherence with the recommended life-style and drug interventions

Faculty
Joseph A. Lieberman III, MD, MPH
Professor of Family Medicine
Jefferson Medical College
Thomas Jefferson University
Associate Editor, Delaware Medical Journal
Philadelphia, PA

N. Lawrence Edwards, MD, FACP, FACR
Professor of Medicine
Division of Rheumatology and Clinical Immunology
Program Director and Vice Chairman
Department of Medicine
University of Florida
Gainesville, FL